Dr Andrie Panayiotou is Assistant Professor in Public Health at the Cyprus International Institute for Environmental and Public Health, CUT, since 2011. She is an epidemiologist with special interest in preventing cardiovascular disease and atherosclerosis and her work has focused mainly on risk factors and biomarkers (genetic, biochemical, environmental and social) for cardiovascular health and disease, while she has recently expanded research work to include risk factors for the cardiorenal syndrome and vascular ageing (arterial stiffness as a proxy for CVD), under the “common grounds for disease” hypothesis. Since 2011 she has established and heads the Cardiovascular Epidemiology and Genetics lab at CII (CVEG –www.cveglab.cut.ac.cy), a dry lab, which houses relevant equipment for arterial stiffness measurements (Complior Analyse, ALAm Medical Inc) and data analysis. The CVEG team includes post-graduate/PhD students, as well as MD/research associates. She additionally co-ordinates “The Cyprus Study”, an on-going general population cohort study which she helped set-up and which participates in several large international consortia publishing joint results in high-impact journals such as Nature Genetics, JACC, BMJ and others (see list of publications). She is experienced in study design, logistics, including sample acquiring and storage, and analysis of large epidemiological studies. AP is also the Secretary and founding member of the newly established Cyprus Atherosclerosis Society (CAS), while she also sits at the board of the National Bioethics Committee and heads the Cyprus Unit on Bioethics under the UNESCO Chair in Bioethics (Haifa). She was recently appointed by CAS as National Lead Co-investigator to set-up the Cyprus National Registry for Familial Hypercholesterolemia (Cyprus-FH), part of a global effort on FH (EAS-FHSC).

https://scholar.google.com/citations?user=lPmec0UAAAAJ&hl=en